Pharmaceutical Sciences
Elucidating the mechanism of action of potent and broadly active HIV-1 maturation inhibitors a novel class of anticetroviral drugs
Understading thermodynamic and kinetic factors affecting polymorphism of pharmaceutical ingradients
Development of PD-1/PDL-1 check point inhibitor(s) for adjuvant therapy
Developing in vivo based QSPR model for the in-silico prediction of drugs penetrating through blood retinal barriers for high-throughput ocular drug development
Design of inhibitors against metallo-beta-lactamases and their structural studies to map the drug binding sites
Synthesis, characterization and pharmacokinetic evaluation of potent integrin antagonists for the prevention and treatment of fungal infections
DOS approach for sesquiterpene anti-malaria drugs
Screening lead molecules identified by structure-based rational drug design methods against cytochrome b5 reductase 3 and dopamine beta hydroxylase in spontaneously hypertensive rat models for antihypertensive effects
Screening of miRNA/long-non coding RNAs as potential prognostic/diagnostic biomarker for Hepatitis E
Vaccination and protection studies for a targeted nanoparticulate oral vaccine against shigellosis
Pages
